发布时间：2026-03-17 16:10 Galderma will present nine posters spanning its full aesthetics portfolio at AMWC 2026, highlighting the regenerative benefits of Sculptra, the long-lasting efficacy of Restylane, and the advanced clinical performance of Relfydess (RelabotulinumtoxinA) 1-9
The data reinforce Galderma’s future-focused approach to innovation, addressing emerging patient needs from menopauserelated skin changes to rising interest in body injectables and regenerative treatments
A series of symposia and Masterclasses will further highlight Galderma’s leadership in aesthetics, showcasing how the portfolio supports complex patient profiles and evolving global trends



ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) will present nine abstracts at the Aesthetic & AntiAging Medicine (AMWC) World Congress 2026 in Monaco, showcasing innovative and robust scientific data across its aesthetics portfolio, alongside three symposia, and multiple Masterclasses an
=*=*=*=*=*=
当前为第1/20页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页